170 related articles for article (PubMed ID: 28284893)
1. GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma.
Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic-Radojevic AR; Radojevic-Skodric SM; Matic MG; Suvakov SR; Dragicevic DP; Radic TM; Dzamic ZM; Pljesa-Ercegovac MS
Urol Oncol; 2017 Jun; 35(6):409-417. PubMed ID: 28284893
[TBL] [Abstract][Full Text] [Related]
2. Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma.
Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic Radojevic AR; Radojevic-Skodric SM; Matic MG; Dragicevic DP; Radic TM; Bogdanovic LM; Dzamic ZM; Pljesa-Ercegovac MS
PLoS One; 2016; 11(8):e0160570. PubMed ID: 27500405
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analyses of the relationship between glutathione S-transferase gene polymorphisms and renal cell carcinoma susceptibility.
Zhong Z; Li H; Zhong H; Zhou T; Xie W; Lin Z
BMC Med Genet; 2018 Jun; 19(1):98. PubMed ID: 29884137
[TBL] [Abstract][Full Text] [Related]
4. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma.
Pljesa-Ercegovac M; Savic-Radojevic A; Coric V; Radic T; Simic T
Biofactors; 2020 Mar; 46(2):229-238. PubMed ID: 31483924
[TBL] [Abstract][Full Text] [Related]
5. No association between the GSTM1 null genotype and risk of renal cell carcinoma: a meta-analysis.
Liu R; Wang XH; Liu L; Zhou Q
Asian Pac J Cancer Prev; 2012; 13(7):3109-12. PubMed ID: 22994718
[TBL] [Abstract][Full Text] [Related]
6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis.
Abid A; Ajaz S; Khan AR; Zehra F; Hasan AS; Sultan G; Mohsin R; Hashmi A; Niamatullah N; Rizvi SA; Mehdi SQ; Khaliq S
Urol Oncol; 2016 Sep; 34(9):419.e1-419.e12. PubMed ID: 27185341
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
9. Association of glutathione S-transferase M1, T1, and P1 polymorphisms with renal cell carcinoma: evidence from 11 studies.
Jia CY; Liu YJ; Cong XL; Ma YS; Sun R; Fu D; Lv ZW
Tumour Biol; 2014 Apr; 35(4):3867-73. PubMed ID: 24337975
[TBL] [Abstract][Full Text] [Related]
10. Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma.
Ahmad ST; Arjumand W; Seth A; Kumar Saini A; Sultana S
DNA Cell Biol; 2012 Apr; 31(4):636-43. PubMed ID: 22054067
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
12. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
13. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
14. Association between GSTM1, GSTT1, and GSTP1 variants and the risk of end stage renal disease.
Nomani H; Hagh-Nazari L; Aidy A; Vaisi-Raygani A; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Mozaffari HR; Tavilani H; Pourmotabbed T
Ren Fail; 2016 Oct; 38(9):1455-1461. PubMed ID: 27498857
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals.
Buzio L; De Palma G; Mozzoni P; Tondel M; Buzio C; Franchini I; Axelson O; Mutti A
Occup Environ Med; 2003 Oct; 60(10):789-93. PubMed ID: 14504370
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene.
De Martino M; Klatte T; Schatzl G; Remzi M; Waldert M; Haitel A; Stancik I; Kramer G; Marberger M
J Urol; 2010 Mar; 183(3):878-83. PubMed ID: 20083259
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms.
Karami S; Boffetta P; Rothman N; Hung RJ; Stewart T; Zaridze D; Navritalova M; Mates D; Janout V; Kollarova H; Bencko V; Szeszenia-Dabrowska N; Holcatova I; Mukeria A; Gromiec J; Chanock SJ; Brennan P; Chow WH; Moore LE
Carcinogenesis; 2008 Aug; 29(8):1567-71. PubMed ID: 18566013
[TBL] [Abstract][Full Text] [Related]
18. GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Serrano-Oviedo L; Gimenez-Bachs JM; Martínez-Sanchiz C; Segura-Martín M; Escribano J
Urol Oncol; 2012; 30(6):864-70. PubMed ID: 21458313
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.
Tan X; Wang Y; Han Y; Chang W; Su T; Hou J; Xu D; Yu Y; Ma W; Thompson TC; Cao G
Br J Cancer; 2013 Dec; 109(12):3105-15. PubMed ID: 24157827
[TBL] [Abstract][Full Text] [Related]
20. The Association of Polymorphisms in
Mihailovic S; Coric V; Radic T; Radojevic AS; Matic M; Dragicevic D; Djokic M; Vasic V; Dzamic Z; Simic T; Hadzi-Djokic J; Pljesa Ercegovac M
Oxid Med Cell Longev; 2021; 2021():6617969. PubMed ID: 33953831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
